Jyong Biotech MENS
NASDAQ MENS
$2.18 +0.15 (+7.39%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jyong Biotech (MENS) Cash & Equivalents (2024 - 2025)

Updated

Jyong Biotech's Cash & Equivalents came in at $1.18 million for the quarter ended Dec 31, 2025, compared with $98,000 a year earlier.

Analysis

Jyong Biotech (MENS) Cash & Equivalents (2024 - 2025) Analysis & Trends

  • Going back by year, Cash & Equivalents was $98,000 in the year ended Dec 31, 2024 (-95.7%) and $2.27 million in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.42 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.89 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 976.00 Mn
10 Jyong Biotech 165.74 Mn 165.74 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.18 Mn
Jun 30, 2025 132,000.00
Dec 31, 2024 98,000.00
API Access

Jyong Biotech Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MENS&period=max&api_key=YOUR_API_KEY